Example of Fatty Acid-Loaded Lipoplex in Enhancing in Vitro Gene Transfer Efficacies of Cationic Amphiphile
- 26 April 2005
- journal article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 16 (3), 676-684
- https://doi.org/10.1021/bc049687t
Abstract
Herein, we report on the design and synthesis of a novel nontoxic cationic amphiphile N,N-di-n-tetradecyl-N-[2-[N‘,N‘-bis(2-hydroxyethyl)amino]ethyl]-N-(2-hydroxyethyl)ammonium chloride (lipid 1) whose in vitro gene transfer efficacies in CHO, COS-1, MCF-7, and HepG2 cells are remarkably enhanced when used in combination with 30 mole percent added myristic acid. Reporter gene expression assay using p-CMV-SPORT-β-gal reporter gene revealed poor gene transfer properties of the cationic liposomes of lipid 1 and cholesterol (colipid). However, the in vitro gene delivery efficacies of lipid 1 were found to be remarkably enhanced when the cationic liposomes of lipid 1 and cholesterol were prepared in the presence of 30 mole percent added myristic acid (with respect to lipid 1) as the third liposomal ingredient. The whole cell histochemical X-gal staining of representative CHO cells further confirmed the significantly enhanced gene transfer properties of the fatty acid-loaded cationic liposomes of lipid 1 and cholesterol. Electrophoretic gel patterns in the gel mobility shift assay supports the notion that better DNA release from fatty acid lipoplexes might play a role in their enhanced gene transfer properties. In addition, such myristic acid-loaded lipoplexes of lipid 1 were also found to be serum-compatible up to 30% added serum. Taken together, our present findings demonstrate that the transfection efficacies of fatty acid-loaded lipoplexes are worth evaluating particularly when traditional cationic liposomes prepared with either cholesterol or DOPE colipids fail to transfect cultured cells.Keywords
This publication has 20 references indexed in Scilit:
- Design, Syntheses and In Vitro Gene Delivery Efficacies of Novel Mono-, Di- and Trilysinated Cationic Lipids: A Structure−Activity InvestigationJournal of Medicinal Chemistry, 2004
- Single histidine residue in head-group region is sufficient to impart remarkable gene transfection properties to cationic lipids: evidence for histidine-mediated membrane fusion at acidic pHGene Therapy, 2003
- Molecular Shape of the Cationic Lipid Controls the Structure of Cationic Lipid/Dioleylphosphatidylethanolamine-DNA Complexes and the Efficiency of Gene DeliveryJournal of Biological Chemistry, 2001
- Cation Substitution in Cationic Phosphonolipids: A New Concept To Improve Transfection Activity and Decrease Cellular ToxicityJournal of Medicinal Chemistry, 2000
- Novel Series of Non-Glycerol-Based Cationic Transfection Lipids for Use in Liposomal Gene DeliveryJournal of Medicinal Chemistry, 1999
- Phosphonolipids as non-viral vectors for gene therapyEuropean Journal of Medicinal Chemistry, 1998
- A Controlled Study of Adenoviral-Vector–Mediated Gene Transfer in the Nasal Epithelium of Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Liposome‐Mediated Gene Transfer into Normal and Dystrophin‐Deficient Mouse MyoblastsJournal of Neurochemistry, 1995
- Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisNature Genetics, 1994
- Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992